Semax Benefits: The Claims, Against the Numbers
Most semax benefits lists cite an evidence base a Western reader cannot open. Here is what each claim rests on, in which organism, and what the vial adds.
MEDICAL DISCLAIMER: Educational research guidelines only. Lyophilized peptides are investigational chemical compounds and are NOT approved for human consumption, diagnosis, or therapy. Consult a licensed physician before any research application.
The usual complaint about semax benefits claims is that they have no evidence behind them. That complaint is wrong, and getting it wrong matters, because the actual situation is more awkward than an empty file. There is a substantial Russian clinical and regulatory record for this compound. A reader in London or Chicago cannot open it, cannot check its methods, and cannot map it onto a vial bought from a research chemical supplier.
This page separates the claims by what stands behind each one, names the organism every time, and then does the part this site exists for: converting a claimed amount into the container that would have to supply it. No amount for a person is recommended anywhere.
Lowest cost per milligram we track
Semax — Ascension Peptides
Independently assayed research material. With the code the 10 mg vial works out at $3.00/mg.
The published certificate for batch 30-05260628 carries a kinetic chromogenic LAL endotoxin test to USP Chapter 85, reporting under 0.20 EU/mL against a 0.5 EU/mL limit, plus a sterility screen. Buying 3, 5 or 10 takes 3%, 5% or 10% off the list price.
- Two third-party assays per batch
- Free carriage over $250
- Same-day dispatch before 2pm CST
Laboratory research material only, not for human consumption. Affiliate links: we may earn a commission at no additional cost to you. Figures checked August 21, 2026.
Which semax benefits have a measurement, and in which organism
Sort the claims by source before arguing about any of them, because the sources are not the same kind of thing.
Claims traceable to Russian clinical use concern people, and they arise from a manufactured medicine used under supervision within one national system. Claims traceable to laboratory work concern rats, mice or cultured cells, and report amounts scaled to animal body weight. Claims traceable to forum posts and product copy concern nobody in particular and carry no measurement at all. Those three categories get flattened into a single bullet list on most product pages, which is where the trouble starts.
Where the claims come from, and why that matters more than usual
For most research chemicals the honest summary is that human evidence does not exist. Here it does exist, in a system whose outputs are largely not retrievable through the databases a Western reader can reach, and are not accompanied by a registration dossier anyone outside can examine.
There are no registered interventional trials for this compound on ClinicalTrials.gov, so no trial identifier appears on this page. A text search of that registry will return records that mention the word and turn out to study something unrelated, and quoting one of those as evidence would be worse than citing nothing.
The result is a specific and unusual problem. It is not that the claims are unsupported. It is that support of one kind exists, in a form that cannot be audited from outside, attached to a product that is not the product being sold as a research chemical. Transferability is the question, and no amount of enthusiasm on either side resolves it.
The claims lined up against what stands behind them
| Claim as usually written | Kind of source offered | Organism | What this page can confirm |
|---|---|---|---|
| Improves attention and mental performance | Russian clinical use | Humans | That the use is real, not that a Western reader can check the data |
| Protects neurons after injury | Laboratory studies | Rats and mice | That such work exists in rodents at amounts per kilogram of body weight |
| Acts on neurotrophic signalling | Laboratory studies | Rodent tissue and cultured cells | That mechanism work is in cells and animals, not people |
| Lifts mood or reduces anxiety | Mostly user reports | Humans, unblinded and self assessed | Nothing measurable |
| Works within minutes of a spray | Product copy | Unspecified | Nothing at all |
The fourth and fifth rows carry the same confidence in marketing text as the first, and considerably less behind them. That is the pattern worth taking away rather than any single row.
From a claimed amount to the container that would supply it
Where this site can be exact is on the containers, so take a claimed figure and see what it costs in hardware. Assume a product page attaches a benefit to 600 mcg a day. The figure is assumed for the arithmetic and is not a recommendation.
In the spray branch, assume a bottle stated at 3 mg in 3 mL, which is 1 mg per mL, with a pump rated 0.1 mL. Each stroke carries 100 mcg, so 600 mcg is six strokes a day. Usable yield after an assumed three priming strokes and 0.25 mL of unreachable residual is 2.45 mL, which is 24 whole actuations. Six a day empties the bottle in four days.
In the vial branch, assume 10 mg reconstituted with 2 mL, which is 5 mg per mL. Volume for 600 mcg is 0.6 divided by 5, which is 0.12 mL, or 12 units on a U-100 barrel. Two millilitres at 0.12 mL per session gives 16 sessions, so the vial covers 16 days.
Same claimed figure, same compound, four days against sixteen. Anyone quoting a benefit at a daily amount without naming the container has left out the number that decides whether the claim is even affordable to test.
The cost comparison follows from the same figures without needing a price. Let the bottle cost B and the vial cost V. Per day at the assumed 600 mcg, the spray costs B divided by four and the vial costs V divided by sixteen. For the two to break even, B would have to be a quarter of V, which is not how the two formats are usually priced. A benefit claim stated in sprays therefore tends to be the expensive way to buy the same milligram, and the product page quoting it rarely says so.
What the spray format does to a benefit claim
A vial claim can at least be reconstructed. Labelled mass, recorded fill volume and a barrel reading give a delivered mass anyone can recompute.
A spray claim cannot be reconstructed to the same depth. Mass per actuation is concentration multiplied by the volume the pump releases, and that volume is a hardware specification the buyer takes on trust. Two bottles with identical labels and different pumps deliver different masses per stroke, and nothing visible distinguishes them. When a benefit is quoted in sprays rather than micrograms, the mass has been left undefined by the person making the claim.
There is a second gap the arithmetic cannot close. Delivered mass is not absorbed mass, and how much crosses a nasal membrane is not a division problem. Comparing a nasal figure with an injected figure as though they were the same quantity is a category error that tables like the one above can encourage if read carelessly.
Where a benefit claim stops being arithmetic
Container maths settles what left the container. It settles nothing about what happened afterwards.
The compound holds no authorisation from the FDA, the EMA or the MHRA. Its Russian approval is genuine and describes a pharmaceutical product made to a specification, which is not the same object as a vial of powder shipped as a research chemical. Between those two facts sits every benefit claim on every product page, and the arithmetic on this site can only tell you how much material a container would have to give up for the claim to be tested at all.
That is a narrow contribution, and it is the honest one. The alternative, converting a rodent amount per kilogram into a human figure and presenting the result as a dose, produces a number with no support underneath it and a table beside it, which is the most persuasive form a bad number can take.
Frequently Asked Questions
Is there human evidence for this compound or not?expand_more
There is human clinical use in Russia, which is human evidence. It is not evidence a reader outside that system can inspect, and it attaches to a manufactured medicine rather than to a research chemical vial. Both halves of that sentence are needed.
Do the rat and mouse findings support the cognitive claims?expand_more
They support the existence of effects in rodents at amounts scaled to animal body weight. They do not establish a benefit in people, and the conversion from one to the other is not arithmetic this page will perform.
Why do product pages quote sprays instead of micrograms?expand_more
Because sprays are countable and micrograms require a pump rating. Quoting strokes lets a claim look precise while leaving the delivered mass undefined.
Does a stronger concentration produce a larger benefit?expand_more
Concentration changes the mass in a given volume, nothing else. A benefit claim tied to a concentration rather than to a delivered mass has skipped a step.
What single piece of evidence would change this page most?expand_more
An independent registration programme conducted where its dossier could be examined, reporting in people, on a product with a stated specification. Nothing smaller than that closes the transferability gap.